Illustration: Gabriella Turrisi/Axios
Hinge Health is targeting a nearly $2.6 billion valuation in its IPO — less than half of what it was worth four years ago.
Why it matters: Widely anticipated as a bellwether of future activity, Hinge's initial pricing doesn't bode well, particularly for its investors.
